Novadiscovery
Lyon, France
Novadiscovery is a de-risking technology provider specialized in in silico clinical trials supporting biotech and pharma companies, academic research centers and not-for-profit organizations. We help our clients unlock the potential of modeling & simulation to de-risk the R&D of new therapies for the benefit of patients. Based on the Effect Model law, our pioneering approach enables the prediction of the effectiveness of a therapy or the diagnostic value of a biomarker, at the individual and the population level, and compare them with those of competitors. Nova optimizes drug R&D and strengthens healthcare decision-making.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2010
- Website
- www.novainsilico.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Novadiscovery?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now